TScan Therapeutics, Inc. (TCRX)

NASDAQ: TCRX · IEX Real-Time Price · USD

8.56

-0.09 (-1.04%)

At close: May 3, 2024, 4:00 PM

8.73

+0.17 (1.99%)

After-hours: May 3, 2024, 4:49 PM EDT

TScan Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-89.22	-66.22	-48.63	-26.13	-13.66
Depreciation & Amortization	5.36	5.14	3.33	1.23	0.52
Share-Based Compensation	5.21	4.55	2.52	0.52	0.24
Other Operating Activities	17.29	-9.97	-5.9	21.36	0.38
Operating Cash Flow	-61.36	-66.5	-48.68	-3.02	-12.52
Capital Expenditures	-3.15	-4.23	-9.94	-4.24	-1.25
Change in Investments	-57.61	0	0	0	0
Investing Cash Flow	-60.76	-4.23	-9.94	-4.24	-1.25
Share Issuance / Repurchase	43.13	0.33	89.94	0.29	0.01
Debt Issued / Paid	0	29.03	0	0	0
Other Financing Activities	92.32	-	99.73	-	34.81
Financing Cash Flow	135.44	29.36	189.67	0.29	34.81
Net Cash Flow	13.33	-41.37	131.05	-6.97	21.04
Free Cash Flow	-64.5	-70.73	-58.62	-7.26	-13.77
Free Cash Flow Margin	-306.45%	-522.56%	-578.03%	-669.22%	-
Free Cash Flow Per Share	-0.98	-2.94	-5.03	-7.93	-35.76

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).